FDA Investigator Joslyn K Brunelle, PhD
Joslyn K Brunelle, PhD has inspections in 1 countries as of 23 Jun 2023. Joslyn K Brunelle, PhD has collaborated with a combined 1508 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
23 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Andrew W Harmon,
Angel K Sandhu,
Anh M Lac,
Ashar P Parikh,
Bo Chi, PhD,
Brian A Roelofs,
Candace Y Gomez Broughton,
Carl Lee,
Carolyn A Renshaw,
CDR Rochelle B Young, RPh, MSA,
Cristina Ausin Moreno, PhD,
Cristina Ausin Moreoo, PhD,
Diane L Raccasi,
Dilip Devineni, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Eboni S Funderburk,
Edwin Jao,
Eileen A Liu,
Emilie E Kahn,
Emmanuel Adu Gyamfi,
Eric M Mueller, PharmD,
Esther C Broner, PhD,
Henry K Lau,
Hung H Do, MS,
Hyung Yul Lee,
Ian L Mcwilliams,
James A Lane,
Jeffrey D Meng,
Jeffrey M Watson,
Jolanna A Norton,
Jon P Antoniou,
Joseph A Piechocki,
Kalavati Suvarna, PhD,
Kevin P Foley,
Kula N Jha,
Lance M De Souza, MBA,
Laura Fontan, MS,
Laurie Graham,
LCDR Sean Byrd,
Logan T Williams,
Maria Cruz Fisher,
Maria I Cruz Fisher,
Massod Rahimi, PhD,
Meisha R Sampson,
Meisha Waters,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele Perry Williams,
Muna Algharibeh,
Muna Alghribeh,
Nicholas L Paulin,
Paula A Trost,
Prabhu P Raju,
Rabia Ballica, PhD,
Raymond T Oji,
Richard Ledwidge (nmi), PhD,
Robert Barbosa,
Robert J Ham,
Robert M Barbosa,
Sandra A Boyd,
Sargum C Sood,
Scott R Nichols, PhD,
Sean R Bryd,
Sherri J Jackson,
Sidney B Priesmeyer,
Sneha S Patel,
Steven D Kehoe,
Tara L Greene,
Tara L King,
Thomas J Arista,
Thomas R Withers,
Timothy J Schmidt,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Vaishali J Patel,
Warren J Lopicka,
Wayne E Seifert,
William V Millar,
Yanming An, PhD,
Ying Xin Fan, PhD,
Yiyue Zhang (nmi), PhD,
Zhang Zhao, PhD
Joslyn K Brunelle, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2017 | EIR | BioMarin Pharmaceutical Inc. - EIR, 2017-12-14 |
December, 2017 | FDA 483 | BioMarin Pharmaceutical Inc. - Form 483, 2017-12-14 |
October, 2018 | FDA 483 | Patheon Biologics LLC - Form 483, 2018-10-09 |
October, 2013 | EIR | Catalent Indiana, LLC - EIR, 2013-10-25 |
October, 2013 | FDA 483 | Catalent Indiana, LLC - Form 483, 2013-10-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more